Sean Cassidy
Net worth: - $ as of 2026-05-30
Net worth: - $ as of 2026-05-30
Sean A. Cassidy currently works at Automera US, Inc., as Director, Renetx Bio, Inc., as Director, HOOKIPA Pharma, Inc., as Independent Director from 2024, Abbratech, Inc., as Director, Arvinas Operations, Inc., as Chief Financial Officer, and The Friends of Yale New Haven Children's Hospital, as Treasurer.
Mr. Cassidy also formerly worked at Deloitte & Touche LLP, as Director & Controller in 2001, 454 Life Sciences Corp., as Director & Controller from 2002 to 2008, CuraGen Corp., as Chief Financial Officer & Vice President from 2008 to 2009, Renetx Bio, Inc., as Chief Financial Officer & VP-Administration in 2013, and Arvinas, Inc., as Chief Financial Officer & Treasurer from 2013 to 2024.
Mr. Cassidy received his Masters Business Admin degree in 2000 from the University of Connecticut and undergraduate degree in 1992 from the University of Connecticut.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HOOKIPA PHARMA INC. -.--% | 2025-06-03 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| HOOA PHARPAR | Director/Board Member | 2024-07-21 |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Director of Finance/CFO | - |
The Friends of Yale New Haven Children's Hospital | Treasurer | - |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Director/Board Member | - |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| ARVINAS, INC. | Director of Finance/CFO | 2024-02-28 |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Director of Finance/CFO | 2013-05-31 |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Director of Finance/CFO | 2009-09-30 |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Director/Board Member | 2008-11-30 |
| ░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
454 Life Sciences Corp.
454 Life Sciences Corp. Medical/Nursing ServicesHealth Services Provides medical testing services to determine the nucleotide sequence of whole genomes | Health Services |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
The Friends of Yale New Haven Children's Hospital | |
HOOKIPA Pharma, Inc.
HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Abbratech, Inc.
Abbratech, Inc. BiotechnologyHealth Technology Develops antibodies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions